Pricing Log in Create free account

Codexis, Inc. (CDXS) vs Canton Strategic Holdings, Inc. (CNTN)

Codexis, Inc. and Canton Strategic Holdings, Inc. are both Biotechnology companies. Codexis, Inc. and Canton Strategic Holdings, Inc. are of similar size ($149.0M and $148.9M). Codexis, Inc. has negative trailing earnings, so its P/E is not meaningful; Canton Strategic Holdings, Inc. trades at 9.0×. Canton Strategic Holdings, Inc. has the higher net margin (0.00% vs −39.6%) and the higher return on invested capital (−8.11% vs −151.2%). Across the 13 metrics below, Canton Strategic Holdings, Inc. leads on 12 and Codexis, Inc. on 1.

Valuation

Metric CDXS CNTN Biotechnology median
P/E n/m 9.01 8.50
P/S 1.45 n/m 9.71
P/B 3.43 0.81 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 1.18 n/m 9.21
Earnings yield (27.42%) 11.10% (33.15%)
Free cash flow yield (10.77%) (6.01%) (25.50%)

Profitability

Metric CDXS CNTN Biotechnology median
Gross margin 87.02% — 65.16%
Operating margin (35.61%) 0.00% 0.00%
Net margin (39.55%) 0.00% 0.00%
Free cash flow margin (15.66%) 0.00% 0.00%
Return on equity (69.36%) (43.10%) (56.36%)
Return on assets (23.79%) (34.60%) (48.04%)
Return on invested capital (151.17%) (8.11%) 0.00%

Growth

Metric CDXS CNTN Biotechnology median
Revenue growth (TTM) 35.89% — 6.02%
EPS growth (last fiscal year) 43.82% 88.10% 30.26%
Revenue growth, 5-year CAGR 0.38% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CDXS CNTN Biotechnology median
Debt to equity 1.03 0.00 0.00
Current ratio 3.06 15.70 4.72
Net debt to EBITDA 1.11 0.85 0.96

Dividend

Metric CDXS CNTN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CDXS CNTN Biotechnology median
Market cap 148.93m 149.01m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack